Selection criteria for radionuclides to be used in radioimmunotherapy are reviewed. Among the topics covered are half‐life, specific activity, type of emission, and ease of preparation. (AIP)
No takes yet. Share an insight, caveat, or question.
Mausner et al. (1993) studied this question.